A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)

NCT00420784 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Telaprevir
DRUG: Ribavirin
DRUG: Pegylated Interferon Alfa 2a
DRUG: Matching Placebo

Sponsor

Vertex Pharmaceuticals Incorporated